Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis DatabaseChangsu L Park, Ramy Saleh, Feras A. Moria et al.|Current Oncology|2024Cited by 9
Effectiveness of first-line therapy in patients with advanced non-clear renal cell carcinoma (nccRCC).Sophie Laramee, Aly‐Khan A. Lalani, Sunita Ghosh et al.|Journal of Clinical Oncology|2022Cited by 2
Interim results of PDL1V (PF-08046054), a vedotin-based ADC targeting PD-L1, in patients with NSCLC in a phase 1 trial.Elisa Fontana, Ramy Saleh, Anna Minchom et al.|Journal of Clinical Oncology|2025Cited by 2
Impact of timing of immunotherapy and cytoreductive nephrectomy on outcomes in metastatic renal cell carcinoma: Results from the CKCis database.Changsu Park, Ramy Saleh, Sunita Ghosh et al.|Journal of Clinical Oncology|2024Cited by 0
Head-to-head comparison of pembrolizumab-axitinib versus pembrolizumab-lenvatinib in metastatic RCC: Real world data from the Canadian Kidney Cancer Information System (CKCis) database.Alexandre da Silva Faco, Ramy Saleh, Mohammad Amin Salehi et al.|Journal of Clinical Oncology|2026Cited by 0